Life Sciences

FDA reopens comment period for hemostatic devices

Device Regulation Alert: Safety, Compliance and Reimbursement News, September 22, 2008

For the second time, the FDA is reopening the comment period on its proposed guidance concerning reclassification of absorbable hemostatic devices. The public has until October 14 to comment.

The agency released the draft guidance “Class II Special Controls Guidance Document: Absorbable Hemostatic Device” for comment in October 2006, according to the Federal Register. The FDA had previously reopened the comment period in May 2007.

The FDA received a petition last year requesting it not issue a final rule and the draft guidance until it made public an updated administrative record. The petition also asked the agency to reopen the rulemaking process.

Comments

0 comments on “FDA reopens comment period for hemostatic devices

 

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Complete Guide to Lab Safety, 3rd Ed.

    The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...

Most Popular